Pandemic akin to war, lawyer tells Covid inquiry
Decisions were “finely balanced” and, with hindsight, might have been different, Fiona Scolding KC says.
Similar Posts
Toxic debate over lab leak theory hampers search for Covid origins
US agencies cannot agree on how the pandemic started, with the scientific community bitterly divided.
To reduce cancer risk, skip the alcohol, report suggests: ‘No safe amount’
For those participating in “Dry January,” another potential benefit of giving up alcohol has emerged. Giving up alcoholic drinks — or reducing the amount that’s consumed — could reduce the risk of getting oral or esophageal cancer, according to a special report published in The New England Journal of Medicine on Dec. 28. Researchers from…
More Hospitals Require Masks As Flu And COVID-19 Cases Surge
NEW YORK (AP) — More U.S. hospitals are requiring masks and limiting visitors as health officials face an expected but still nasty post-holiday spike in flu, COVID-19 and other illnesses. While many experts say this season likely won’t prove to be as deadly as some other recent winters, it still could mean hundreds of thousands…
Cigna explores shedding Medicare Advantage business | Reuters News Agency
DealsGovernmentHealth 06 November 2023, 6:28 pm 1 minute Reuters was first to report that U.S. health insurer Cigna Group (CI.N) is exploring the sale of its Medicare Advantage business, which manages government health insurance for people aged 65 and older, a move that would mark a reversal of its expansion in the sector.  Market Impact…
Volunteers breathe polluted air to test impact on brain
“Over the last 10 years, we have begun to see statistical associations between air pollution and a whole range of brain-related issues – all the way from how children learn, the way in which their cognition changes, to mental health and increased risks of dementia.
Most patients using weight-loss drugs like Wegovy stop within a year, data show | Reuters News Agency
Health 11 July 2023, 5:39 pm 1 minute Reuters exclusively reported that Only about one-third of patients prescribed a popular weight-loss drug like Novo Nordisk’s (NOVOb.CO) Wegovy were still taking it a year later, while total healthcare costs for the group rose sharply. Market Impact Shares of the Danish drugmaker fell 2.3% on Tuesday. Article…
